MAYO CLINIC AND ROYAL BROMPTON Challenging Case Studies – 2026

The meeting will focus on Interstitial Lung Diseases (ILDs), Pulmonary Vasculitis, Genetic Diseases and Pulmonary Hypertension. The field is rapidly evolving with new diagnostic classifications, emerging biomarkers and innovative therapies. The program will offer clinical, radiological and pathology cases discussed with international experts.

Learning Objectives

• Build knowledge on state‑of‑the‑art ILD diagnosis, including the new ILD classification.
• Discuss the current rationale of clinical–radiological–pathological integration in ILDs.
• Recognize and manage pulmonary hypertension in the context of ILDs and rare diseases.
• Evaluate fibrotic and non‑fibrotic ILD patterns (UIP, BIP and alternative patterns).
• Explore advanced diagnostic tools including radiomix, genetics, serology, biomarkers.
• Compare international approaches and integrate experience from world experts